PA
SBSW icon

PharVision Advisers’s Sibanye-Stillwater SBSW Stock Holding History

PharVision Advisers’s Portfolio SBSW Stock Details SBSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,895
Closed -$298K – 546
2025
Q4 		$298K Buy
20,895
+435
+2% +$5.26K 0.15% 278
2025
Q3 		$230K Buy
+20,460
New +$179K 0.13% 391

Other funds holding SBSW

LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
Condire Management Dallas, Texas $942M AUM 83.43% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $24.4B AUM 40.93% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

PharVision Advisers's SBSW Position: Q1 2026 in Review

PharVision Advisers sold out of Sibanye-Stillwater (SBSW) in Q1 2026, closing a stake of 20,895 shares — an estimated $298K sold.

PharVision Advisers first reported a position in SBSW in Q3 2025 and held it in 2 quarters. The position peaked at $298K in Q4 2025. 271 funds tracked by Wall St. Rank hold SBSW as of Q1 2026.

  • PharVision Advisers reported no remaining Sibanye-Stillwater position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 20,895 Sibanye-Stillwater shares in Q1 2026, an estimated $298K.
  • PharVision Advisers first reported a position in Sibanye-Stillwater in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Sibanye-Stillwater position peaked at $298K in Q4 2025.
  • 271 funds tracked by Wall St. Rank held Sibanye-Stillwater as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.